tradingkey.logo

Semler Scientific Inc

SMLR
View Detailed Chart
27.600USD
+0.180+0.66%
Close 11/07, 16:00ETQuotes delayed by 15 min
377.80MMarket Cap
10.20P/E TTM

Semler Scientific Inc

27.600
+0.180+0.66%
Intraday
1m
30m
1h
D
W
M
D

Today

+0.66%

5 Days

+4.31%

1 Month

-2.68%

6 Months

-16.49%

Year to Date

-48.89%

1 Year

-27.23%

View Detailed Chart

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Semler Scientific Inc's Score

Industry at a Glance

Industry Ranking
88 / 209
Overall Ranking
185 / 4614
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 3 analysts
Buy
Current Rating
75.333
Target Price
+174.74%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Semler Scientific Inc Highlights

StrengthsRisks
Semler Scientific, Inc. develops, manufactures, and markets products and services that assist in evaluating and treating chronic diseases. The Company provides technology solutions to healthcare providers. The Company's flagship product, QuantaFlo is a four-minute in-office blood flow test. Healthcare providers can use blood flow measurements as part of their examinations of a patient’s vascular condition, including assessments of patients who have vascular disease. QuantaFlo features a sensor clamp that is placed on the toe or finger. Infrared light emitted from the clamp on the dorsal surface of the digit is scattered and reflected by the red blood cells coursing through the area of illumination. Returning light is sensed by the sensor. A blood flow waveform is instantaneously constructed by its proprietary software algorithm. Its customers for QuantaFlo include insurance plans, physician groups, risk assessment groups, hospitals and retailers.
Growing
The company is in a growing phase, with the latest annual income totaling USD 56.29M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 56.29M.
Undervalued
The company’s latest PE is 5.53, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 11.18M shares, increasing 2.24% quarter-over-quarter.
Held by HACAX
Star Investor HACAX holds 31.00 shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of 0.24.

Semler Scientific Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Semler Scientific Inc Info

Semler Scientific, Inc. develops, manufactures, and markets products and services that assist in evaluating and treating chronic diseases. The Company provides technology solutions to healthcare providers. The Company's flagship product, QuantaFlo is a four-minute in-office blood flow test. Healthcare providers can use blood flow measurements as part of their examinations of a patient’s vascular condition, including assessments of patients who have vascular disease. QuantaFlo features a sensor clamp that is placed on the toe or finger. Infrared light emitted from the clamp on the dorsal surface of the digit is scattered and reflected by the red blood cells coursing through the area of illumination. Returning light is sensed by the sensor. A blood flow waveform is instantaneously constructed by its proprietary software algorithm. Its customers for QuantaFlo include insurance plans, physician groups, risk assessment groups, hospitals and retailers.
Ticker SymbolSMLR
CompanySemler Scientific Inc
CEODr. Douglas Murphy Chutorian, M.D.
Websitehttps://www.semlerscientific.com/
KeyAI